Scientific and Medical Equipment House Company (TADAWUL:4014)
Saudi Arabia · Delayed Price · Currency is SAR 26.80
-0.42 (-1.54%)
Sep 28, 2026, 3:10 PM AST
TADAWUL:4014 Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 804 | 952 | 1,515 | 1,433 | 1,222 | - | |
Market Cap Growth | -29.21% | -37.19% | 5.76% | 17.23% | - | - |
Enterprise Value | 948 | 1,097 | 1,614 | 1,753 | 1,450 | - |
Last Close Price | 26.80 | 30.71 | 47.57 | 44.11 | 37.63 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 29.19 | 33.46 | 57.90 | 35.76 | 69.56 | - |
Forward PE | - | 31.28 | 31.28 | 27.29 | - | - |
PS Ratio | 1.02 | 1.09 | 1.73 | 1.84 | 1.71 | - |
PB Ratio | 1.64 | 1.90 | 3.00 | 2.83 | 2.61 | - |
P/TBV Ratio | 1.62 | 1.88 | 2.97 | 2.82 | 2.62 | - |
P/FCF Ratio | 10.65 | 570.81 | 5.39 | - | 9.16 | - |
P/OCF Ratio | 9.87 | 108.82 | 5.30 | - | 8.33 | - |
PEG Ratio | - | 3.13 | 3.13 | 3.13 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.20 | 1.25 | 1.84 | 2.26 | 2.03 | - |
EV/EBITDA Ratio | 20.13 | 23.80 | 24.74 | 20.42 | 30.38 | - |
EV/EBIT Ratio | 30.13 | 30.14 | 29.44 | 23.52 | 40.08 | - |
EV/FCF Ratio | 12.55 | 657.92 | 5.74 | - | 10.86 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.48 | 0.38 | 0.41 | 0.72 | 0.44 | 0.56 |
Debt / EBITDA Ratio | 4.94 | 3.54 | 2.79 | 3.80 | 3.82 | 2.79 |
Debt / FCF Ratio | 3.08 | 114.87 | 0.74 | - | 1.55 | - |
Net Debt / Equity Ratio | 0.31 | 0.34 | 0.24 | 0.68 | 0.32 | 0.47 |
Net Debt / EBITDA Ratio | 3.79 | 3.71 | 1.84 | 4.03 | 3.19 | 2.42 |
Net Debt / FCF Ratio | 2.02 | 102.59 | 0.43 | -2.22 | 1.14 | -2.78 |
Asset Turnover | 0.79 | 0.93 | 0.85 | 0.76 | 0.73 | 0.73 |
Inventory Turnover | 10.87 | 8.93 | 7.15 | 6.39 | 5.75 | 5.96 |
Quick Ratio | 1.89 | 2.10 | 1.95 | 1.64 | 1.78 | 1.61 |
Current Ratio | 2.15 | 2.44 | 2.41 | 1.97 | 2.21 | 1.99 |
Return on Equity (ROE) | 5.02% | 5.21% | 6.17% | 9.64% | 3.31% | 16.99% |
Return on Assets (ROA) | 1.97% | 2.41% | 3.33% | 4.58% | 2.32% | 5.40% |
Return on Invested Capital (ROIC) | 3.40% | 3.66% | 5.05% | 7.66% | 3.10% | 12.15% |
Return on Capital Employed (ROCE) | 5.40% | 6.20% | 9.30% | 12.50% | 6.50% | 15.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.43% | 2.99% | 1.73% | 2.80% | 1.44% | - |
FCF Yield | 9.39% | 0.18% | 18.57% | -10.86% | 10.92% | - |
Dividend Yield | 3.73% | - | 2.10% | 2.27% | - | - |
Payout Ratio | 108.92% | 105.49% | 114.64% | - | 113.85% | 38.70% |
Total Shareholder Return | 3.73% | - | 2.10% | 2.27% | - | - |